HSBC Holdings’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.5M Buy
+338,886
New +$9.55M ﹤0.01% 977
2025
Q4
Sell
-242,611
Closed -$8.66M 3112
2025
Q3
$8.66M Buy
242,611
+29,445
+14% +$1.34M ﹤0.01% 981
2025
Q2
$12.3M Buy
213,166
+50,122
+31% +$2.83M 0.01% 840
2025
Q1
$9.5M Buy
163,044
+20,234
+14% +$1.38M 0.01% 909
2024
Q4
$11.5M Sell
142,810
-11,021
-7% -$942K 0.01% 894
2024
Q3
$12.3M Buy
+153,831
New +$10.9M 0.01% 861
2024
Q2
Sell
-133,633
Closed -$6.59M 3124
2024
Q1
$6.59M Buy
133,633
+26,763
+25% +$1.27M ﹤0.01% 1005
2023
Q4
$4.48M Buy
106,870
+25,440
+31% +$866K ﹤0.01% 1189
2023
Q3
$2.67M Buy
81,430
+8,064
+11% +$275K ﹤0.01% 1330
2023
Q2
$2.59M Buy
+73,366
New +$2.43M ﹤0.01% 1330

Other funds holding PRCT

HSBC Holdings's PRCT Position: Q1 2026 in Review

HSBC Holdings opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 338,886 shares worth $8.5M. The stake represents ﹤0.01% of the portfolio and ranks #977 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in PRCT as recently as Q3 2025.

HSBC Holdings first reported a position in PRCT in Q2 2023 and has held it in 10 quarters since. The position peaked at $12.3M in Q3 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • HSBC Holdings held 338,886 shares of Procept Biorobotics worth $8.5M as of Q1 2026.
  • Procept Biorobotics was a new HSBC Holdings position in Q1 2026.
  • Procept Biorobotics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #977 holding.
  • HSBC Holdings first reported a position in Procept Biorobotics in Q2 2023 and has held it in 10 quarters since.
  • HSBC Holdings's Procept Biorobotics position peaked at $12.3M in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.